Jacobson Pharma Corporation Limited (HKG:2633)

Hong Kong · Delayed Price · Currency is HKD

1.090

0.00 (0.00%)

Jun 18, 2026, 3:58 PM HKT

-33.13% (1Y)

Market Cap	2.18B -16.2%
Revenue (ttm)	1.53B -1.9%
Net Income	302.58M +19.5%
EPS	0.15 +17.4%
Shares Out	2.00B
PE Ratio	7.18
Forward PE	7.96
Dividend	0.10 (8.94%)
Ex-Dividend Date	n/a

Volume	120,000
Open	1.100
Previous Close	1.090
Day's Range	1.090 - 1.100
52-Week Range	1.080 - 1.780
Beta	0.22
Analysts	Strong Buy
Price Target	2.45 (+124.77%)
Earnings Date	Jun 23, 2026

About HKG:2633

Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally. It operates in two segments, Generic Drugs and Branded Healthcare. The company offers generic drugs for various therapeutic categories, including cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatological, and anti-allergic. It... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2016

Employees 1,792

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2633

Full Company Profile

Financial Performance

In fiscal year 2025, HKG:2633's revenue was 1.58 billion, an increase of 7.43% compared to the previous year's 1.47 billion. Earnings were 300.83 million, an increase of 12.69%.

Financial Statements